TickerRisk
Learn Pricing Open Scanner

ABBOTT LABORATORIES (ABT) Options Risk Score

Real-time risk analysis for ABT options traders — updated every 30 minutes.

100
HIGH Risk
71.8
IV Rank
35.5%
IV %
2026-10-14
Next Earnings
Pharmaceutical Preparations
Sector

Data last updated: 2026-09-07

Run a full ABT options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.


Scan ABT Now — Free →

Is it risky to sell options on ABBOTT LABORATORIES (ABT) right now?

ABBOTT LABORATORIES (ABT) currently scores 100 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. What pushes it there: an upcoming earnings report, 11 recent news items, 10 active legal filings, 2 recent SEC events and 30 clinical-trial catalysts, all landing inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on ABT is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.

ABT shows an IV Rank of 72 — implied volatility is near the top of its own one-year range, so ABT options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 35%. Read IV Rank alongside the catalyst score: it says how expensive ABT options are, while the score says whether that price is justified by a scheduled event.

ABT reports on 2026-10-14. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

ABBOTT LABORATORIES (ABT) current implied volatility and IV Rank

ABT is trading at an IV Rank of 72 with implied volatility around 35%, alongside a TickerRisk options-risk score of 100/100. That sits near the top of its own 12-month range, so the chain is pricing richly. Sellers are being paid well here — but rich premium and a scheduled event usually arrive together, so check the catalyst list before writing anything.

IV Rank is an index, not a percentage — it says where ABT's implied volatility sits inside its own 1-year range. How to read IV Rank →

ABBOTT LABORATORIES (ABT) next earnings date — 2026-10-14

ABBOTT LABORATORIES (ABT) is scheduled to report on 2026-10-14 — about 37 days away, so a standard expiry would carry straight through it. ABT's IV Rank is currently 72. Implied volatility tends to build into the date and drop sharply once results are public. If the premium on ABT looks unusually generous right now, this is the most likely reason.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer